Beals-Hecht syndrome and choroidal neovascularization

Roberto Gallego-Pinazo; Ruth López-Lizcano; José María Millán; J. Fernando Arevalo; J. Luis Mullor; Manuel Díaz-Llopis

Beals-Hecht syndrome and choroidal neovascularization

Roberto Gallego-Pinazo, Ruth López-Lizcano, José María Millán, J. Fernando Arevalo, J. Luis Mullor, Manuel Díaz-Llopis

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.

Original language	English (US)
Pages (from-to)	845-847
Number of pages	3
Journal	Clinical Ophthalmology
Volume	4
Issue number	1
State	Published - 2010
Externally published	Yes

Keywords

Beals-Hecht syndrome
Choroidal neovascularization
Connective tissue disease
Ranibizumab

ASJC Scopus subject areas

Ophthalmology

Cite this

@article{958918b02822414b9af1c9882faab23f,

title = "Beals-Hecht syndrome and choroidal neovascularization",

abstract = "Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.",

keywords = "Beals-Hecht syndrome, Choroidal neovascularization, Connective tissue disease, Ranibizumab",

author = "Roberto Gallego-Pinazo and Ruth L{\'o}pez-Lizcano and Mill{\'a}n, {Jos{\'e} Mar{\'i}a} and {Fernando Arevalo}, J. and {Luis Mullor}, J. and Manuel D{\'i}az-Llopis",

year = "2010",

language = "English (US)",

volume = "4",

pages = "845--847",

journal = "Clinical Ophthalmology",

issn = "1177-5467",

publisher = "Dove Medical Press Ltd.",

number = "1",

}

TY - JOUR

T1 - Beals-Hecht syndrome and choroidal neovascularization

AU - Gallego-Pinazo, Roberto

AU - López-Lizcano, Ruth

AU - Millán, José María

AU - Fernando Arevalo, J.

AU - Luis Mullor, J.

AU - Díaz-Llopis, Manuel

PY - 2010

Y1 - 2010

N2 - Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.

AB - Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.

KW - Beals-Hecht syndrome

KW - Choroidal neovascularization

KW - Connective tissue disease

KW - Ranibizumab

UR - http://www.scopus.com/inward/record.url?scp=77956123848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956123848&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77956123848

SN - 1177-5467

VL - 4

SP - 845

EP - 847

JO - Clinical Ophthalmology

JF - Clinical Ophthalmology

IS - 1

ER -

Beals-Hecht syndrome and choroidal neovascularization

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this